Hold the core; trim only excess event risk.
The stock has repriced faster than estimates, and consensus already sits at the midpoint of management’s Q2 revenue guide. The case for holding is the net-cash balance sheet and a still-reasonable sales multiple; the case for caution is that the print must validate Statsig retention, ARR quality, and AI monetization while gross margin is under pressure.
Do not sell the full position solely to avoid this print. Keep a normal-sized core. If the rally has pushed AMPL above the portfolio’s intended active weight, trim the excess before the close rather than turning an attractive but unproven SaaS recovery into an oversized binary bet. Re-add only after proof: organic ARR remains near the high teens, Statsig’s $16M ARR transfers cleanly, NRR holds at least ~105%, and gross-margin pressure has a credible monetization path.
The expectation bar: a beat is necessary, but not sufficient
Q2 is the quarter ended June 30, 2026 (t); Q1 2026 is t−1; Q2 2025 is t−4; Q2 2024 is t−8. Dollar figures below are USD. Revenue is GAAP; operating income and EPS guidance/consensus are non-GAAP unless noted.
| Metric | Company guide | Consensus freeze | Last baseline | What matters for the stock |
|---|---|---|---|---|
| Q2 revenue | $96.9M–$99.1M midpoint $98.0M, +17.7% YoY | $98.159M mean / $98.0M median $97.4M–$99.9M, 11 estimates | Q1 $93.492M, +16.9% YoY Q2 2025 $83.270M | No cushion: consensus is almost exactly the guide midpoint. A merely in-line print needs strong KPI commentary. |
| Non-GAAP operating income (loss) | $(3.6)M–$(1.6)M midpoint $(2.6)M | Not reliably available in the source set | Q1 $(3.1)M / −3.3% margin | AI inference and Statsig hosting costs cannot look open-ended. Better-than-midpoint with stable growth is the cleanest upside proof. |
| Non-GAAP EPS | $(0.02)–$(0.01) 134.0M basic shares | $(0.0095) mean / $(0.01) median $(0.02)–$(0.0003), 12 estimates | Q1 $(0.02), 133.3M basic shares | Consensus sits at the favorable end of guidance. Revenue, operating margin, and ARR quality matter more than a one-cent EPS print. |
| FY2026 revenue | $397M–$403M midpoint $400M; includes $5M–$7M Statsig revenue | $400.658M mean / $400.139M median $397.5M–$404.1M, 12 estimates | FY2025 $343.2M | Street is only $0.66M above the guide midpoint. A raise driven only by Statsig accounting is weaker than an organic raise. |
| Q3 revenue | To be issued | $102.580M mean 11 estimates | Q3 2025 $88.564M | Initial guidance should preserve mid-teens organic growth after isolating Statsig contribution. |
Whisper and options posture: no defensible external whisper or event-isolating options-implied move was available at the freeze. This is therefore an earnings setup and reaction framework—not a trade-ready volatility instruction.
What is priced in—and what is not
What the price now appears to discount
- A continued high-teens growth profile: revenue and ARR both grew 17% in Q1.
- A largely successful Statsig transition: the shares are +62.6% over three months and +13.2% over one month.
- Some monetization from platform breadth and AI: 77% of ARR was multi-product and 24% came from customers using five or more products in Q1.
- Valuation has rerated from the June initiation, but remains below the 52-week high of $14.49 and is not an extreme SaaS multiple at 3.18× EV / TTM sales.
What the market may still be underpricing
- Upside: Statsig adds data-warehouse-native experimentation, stronger access to data buyers, and a $16M ARR starting base that management said would have been accretive absent purchase-accounting effects.
- Downside: AMPL is absorbing contracts, technology, hosting, and support—not the original operating team. Transition and renewal execution are not yet proved.
- AI usage is increasing inference expense now, while pricing and packaging must still demonstrate value capture.
- Go-to-market leadership and customer-success changes were intended to improve accountability but can still create pipeline and renewal disruption.
Fiscal.ai snapshot; limits solvency risk and supports continued buybacks, but does not eliminate dilution or execution risk.
The stock works if core ARR sustains high-teens growth and Statsig cross-sell lifts future revenue without permanently resetting gross margin.
Management should separate acquired ARR, retained contracts, organic net new ARR, and any churn. A blended headline is insufficient.
KPI dashboard: the operating proof points
| Metric | Q2 2025 (t−4) | Q4 2025 | Q1 2026 (t−1) | Q2 watch / analyst frame | Flag |
|---|---|---|---|---|---|
| Revenue | $83.27M | $91.43M | $93.49M | Consensus $98.16M | Guide midpoint = consensus |
| ARR | $335M | $366M | $374M | Analyst frame $398M–$401M, including $16M Statsig | Require organic/acquired split |
| NRR, period-end | 104% | 105% | 106% | ~105%–106% is acceptable given Q2 new-logo mix commentary | Sequential improvement through Q1 |
| RPO / cRPO growth | Not in current pack | RPO +35% | RPO +31%; cRPO +20% | Need continued cRPO high-teens or better | RPO growth decelerated |
| Customers ≥$100K ARR | Not in current pack | 698 | 727 (+18% YoY) | Maintain mid/high-teens growth | +29 sequentially in Q1 |
| Multi-product ARR | Not in current pack | 74% | 77% | Hold or rise; isolate Statsig effect | Platform thesis progressing |
| Non-GAAP gross margin | Not in current pack | Not in current pack | 74.8% (75% rounded) | Stability near mid-70s plus a monetization plan | −170 bps YoY in Q1 |
| Free cash flow | Not in current pack | $11.2M | $(13.2)M | Seasonal recovery; full-year framework needed | Q1 margin −14% |
The Q2 ARR range is analyst framing, not consensus: $374M Q1 ARR + management’s $16M Statsig starting contribution + approximately $8M–$11M assumed organic sequential net new ARR. It is explicitly a scenario range, not company guidance.
Bull / base / bear reaction map
Bull
Add after proofRevenue: ≥$99.5M. ARR: >$402M with core net new ARR >$12M plus clean Statsig transfer. NRR: ≥106%. Margin: operating loss better than midpoint, gross margin stable or credible path back.
Stock logic: estimates rise because the core and acquired base both work. The upside is not just accounting. Falsifier: headline ARR is boosted by Statsig but organic growth or retention weakens.
Base
HoldRevenue: $98.0M–$99.5M. ARR: $398M–$402M. NRR: 105%–106%. Margin: inside guide; Q3 near $102M–$104M and FY guide maintained or modestly raised.
Stock logic: fundamentals validate but do not outrun the rerating. Expect debate, not a clean multiple expansion. Falsifier: vague Statsig bridge or margin pressure extends without monetization milestones.
Bear
Trim / exit on breakRevenue: <$97.5M. ARR: <$396M or organic net new ARR <$7M. NRR: <105%. Margin: worse than guide or Q3/FY cut.
Stock logic: the rally priced in a cleaner Statsig and AI transition than delivered. Falsifier to the bear case: miss is timing-only with preserved cRPO, retention, and full-year guide.
Five questions that should decide the next action
Portfolio action rules
Hold / add criteria
- Hold now: normal-sized position, long horizon, and tolerance for a double-digit gap.
- Add after the call: core ARR still high teens; Statsig transfer explicit and healthy; NRR ≥106%; FY guide increases organically; gross-margin plan is quantified.
- Bad print but buyable: revenue timing miss with stable cRPO, retention, organic ARR, and FY guide. Do not buy a vague “timing” explanation without leading indicators.
Trim / exit criteria
- Trim before close: only the amount above intended portfolio weight or event-loss budget after the +62.6% three-month move.
- Trim after print: blended ARR growth hides weak organic net new ARR; NRR falls below 105%; or gross-margin pressure worsens without monetization milestones.
- Exit / re-underwrite: FY revenue cut, material Statsig customer loss, organic ARR growth dropping toward low teens, or management cannot reconcile acquired assets and liabilities.
EPS-quality watch: compare non-GAAP EPS to non-GAAP operating income and FCF. Share-count assumptions are rising (134.0M basic for Q2; 145.1M diluted for FY), stock-based compensation remains material, and purchase-accounting/deferred-revenue effects from Statsig can distort the relationship between ARR, GAAP revenue, and profit.
Source posture and evidence ledger
Company/IR facts are separated from market data, consensus, and analyst judgment. No whisper, clean implied move, live portfolio weight, or cost basis was available; the sizing recommendation is therefore conditional on the position’s intended weight and loss budget.
- Official event timing: Amplitude IR, July 15, 2026 announcement and events page. Release after close Aug. 5; webcast 2:00 p.m. PDT / 5:00 p.m. ET.
- Company baseline and guidance: Amplitude, Q1 2026 earnings release, May 6, 2026; Q1 transcript and presentation downloaded through Fiscal.ai/Quartr and stored in the local evidence pack.
- Statsig and post-print commentary: Amplitude CFO at the Needham conference, May 12, 2026, local Fiscal.ai/Quartr transcript. Management described the $16M ARR definition, $5M–$7M FY revenue contribution, deferred-revenue write-down, and 30–60 day infrastructure transition.
- Consensus: Fiscal.ai estimates endpoints for NasdaqCM-AMPL, retrieved Aug. 5, 2026 at approximately 3:15–3:25 p.m. BRT. Revenue mean/median/range and estimate counts are shown; MarketBeat independently displayed $98.16M revenue and $(0.01) EPS.
- Market data: TradingView intraday snapshot shared at 3:23 p.m. BRT ($9.855, $1.307B market cap, 3.18× EV/TTM revenue, +13.21% 1M, +62.62% 3M, −15.77% YTD); Yahoo chart endpoint cross-check $9.85 at 3:25 p.m. BRT; StockAnalysis confirmed issuer, exchange, and Aug. 5 event date.
- Valuation and balance sheet: Fiscal.ai companyStatistics retrieved Aug. 5, 2026: $203.3M net cash, 2.73× NTM EV/sales, $1.172B market cap at its provider snapshot. Differences versus intraday TradingView reflect timing and denominator conventions.
Material missing evidence
No verified portfolio size/cost basis; no external whisper; no clean event-isolating options tenor; no reliable operating-income consensus; no independent Q2 ARR consensus; and no post-May management transcript from the D.A. Davidson conference in the available source set. These gaps limit precision but do not prevent a conditional hold-versus-sell judgment.